SEC Form 4 · accession 0001209191-17-026256
HERON THERAPEUTICS, INC. /DE/ · HRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Waage Christian
Director
Period of report
Apr 5, 2017
Accepted (ET)
Apr 7, 2017 · 4:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000818033
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $13.50 | Apr 5, 2017 | A | 1,125 | A | — | Apr 5, 2027 | Common Stock | 1,125 | 1,125 | D |
Explanation of responses
- F1The stock option vests and becomes exercisable in nine equal monthly installments beginning one month after the date of grant.